PROS1 and cancer: The correlation analysis between immunomodulators and PROS1 expression may reveal the types of cancers that benefit from immunotherapy targeting PROS1. In LGG, PROS1 was positively correlated with most of the 150 analysed immunomodulators (Fig. 13A).